CHRISTODOULOS CHRISTODOULOU, M.D.
Allergy Physician in SAN ANGELO, Texas. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
CHRISTODOULOS CHRISTODOULOU, M.D. reported a CMS MIPS final score of 95.75/100 — above the 83.1 national average — and filed 292 Medicare Part D claims in 2023.
- 95.75/100
- MIPS score · +13 vs avg
- 292
- Part D claims, 2023
- 46%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
CHRISTODOULOS CHRISTODOULOU, M.D.'s MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure
96 Top 21% higher than 79% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
CHRISTODOULOS CHRISTODOULOU, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about CHRISTODOULOS CHRISTODOULOU, M.D.?
High performer (top quartile)Primary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Texas
How Allergy Physician compares to other specialties among Texas providers
Allergy Physician share within Texas
Allergy Physician is one of the more visible NUCC categories in Texas
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Medicare quality performance — MIPS
CHRISTODOULOS CHRISTODOULOU, M.D.'s 2023 MIPS final score plotted against the Allergy Physician national average
- MIPS Final Score
- 95.75/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Allergy Physician) — 95.75/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Specialty volume Allergy Physician US NPIs
95.75/100 MIPS final score — 12.7 pts above the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Allergy Physician.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
CHRISTODOULOS CHRISTODOULOU, M.D. appears in the CMS NPPES registry as a Allergy Physician provider holding M.D. credentials at 2141 HAMILTON WAY, SAN ANGELO, TX, 76904, with a listed phone of (325) 747-2480. NPI 1700140969 was issued on 07/02/2012. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what CHRISTODOULOU most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 292 prescription claims written by this provider, covering 85 Medicare beneficiaries and totaling roughly $114K in drug spend, split 54% brand-name and 46% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 95.75/100 for the 2023 performance year, compared with the national average of 83.1.
Allergy Physician is a narrow specialty nationwide, with 1,019 enrolled providers across 49 states and an average of 755 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1700140969 |
|---|---|
| Specialty | Allergy Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 07/02/2012 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm CHRISTODOULOS CHRISTODOULOU, M.D.'s current license status, disciplinary history, and board certifications with the Texas Medical Board in Texas before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
Hospital and facility affiliations
Facilities where CHRISTODOULOS CHRISTODOULOU, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for CHRISTODOULOS CHRISTODOULOU, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$840
Largest payer
GlaxoSmithKline, LLC.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context — Texas TMB 2023 annual report
Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 — they are NOT specific to CHRISTODOULOS CHRISTODOULOU, M.D.. To verify CHRISTODOULOS CHRISTODOULOU, M.D.'s current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Brand-heavy
54% brand-name claims vs 46% generic, on 292 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 360
- Total Day Supply
- 9,866
- Brand vs Generic
- 54% brand / 46% generic
- Brand Drug Cost
- $108K
- Generic Drug Cost
- $6K
- Antibiotic Claims
- 21
Patient Demographics
- Average Patient Age
- 70.2 years
- Avg HCC Risk Score
- 1.36
- Gender Split
- 71% female / 29% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What CHRISTODOULOS CHRISTODOULOU, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Symbicort
Symbicort
30 claims
- Trelegy Ellipta
Trelegy Ellipta
27 claims
- Albuterol Sulfate …
Albuterol Sulfate Hfa
25 claims
- Fluticasone Propio…
Fluticasone Propionate
24 claims
- Azelastine Hcl
Azelastine Hcl
23 claims
- Arnuity Ellipta
Arnuity Ellipta
22 claims
- Breo Ellipta
Breo Ellipta
16 claims
- Montelukast Sodium
Montelukast Sodium
16 claims
| Drug | Claims |
|---|---|
| Symbicort Budesonide/Formoterol Fumarate | 30 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 27 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 25 |
| Fluticasone Propionate | 24 |
| Azelastine Hcl | 23 |
| Arnuity Ellipta Fluticasone Furoate | 22 |
| Breo Ellipta Fluticasone/Vilanterol | 16 |
| Montelukast Sodium | 16 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 15 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Allergy Physician Overview
How CHRISTODOULOS CHRISTODOULOU, M.D. fits within the Allergy Physician landscape nationally.
CHRISTODOULOS CHRISTODOULOU, M.D.'s 292 claims are below the specialty average of 755.
Nearby Allergy Physician Providers in Texas
Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as CHRISTODOULOU.
Compare Allergy Physician nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Texas
Frequently Asked Questions
What is CHRISTODOULOS CHRISTODOULOU, M.D.'s specialty? ▼
How much does CHRISTODOULOS CHRISTODOULOU, M.D. prescribe under Medicare Part D? ▼
What is CHRISTODOULOS CHRISTODOULOU, M.D.'s Medicare quality score? ▼
Where is CHRISTODOULOS CHRISTODOULOU, M.D. located? ▼
What is CHRISTODOULOS CHRISTODOULOU, M.D.'s NPI number? ▼
Does CHRISTODOULOS CHRISTODOULOU, M.D. prescribe more brand-name or generic drugs? ▼
How many Allergy Physician providers are there in the US? ▼
What drugs does CHRISTODOULOS CHRISTODOULOU, M.D. prescribe most often? ▼
Does CHRISTODOULOS CHRISTODOULOU, M.D. accept Medicare? ▼
How can I verify CHRISTODOULOS CHRISTODOULOU, M.D.'s credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology